Skip to content

Clinical trials

Terminated Alzheimer Disease trials in Finland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Status: Terminated Country / region: Finland Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20082
20093
20141
20154
20162
20172
20184
20191
20201
20212
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche4
Pfizer4
Biogen3
H. Lundbeck A/S3
Novartis Pharmaceuticals3
GlaxoSmithKline2
AbbVie1
Bristol-Myers Squibb1
Eli Lilly and Company1
Janssen Research & Development, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease25
Dementia6
Brain Diseases3
Central Nervous System Diseases2
Cognitive Dysfunction2
Mental Disorders2
Nervous System Diseases2
Neurodegenerative Diseases2
Deglutition Disorders1
Frontotemporal Dementia1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.